BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Natarajan S, Saatçi E, Joseph J. Development and Evaluation of Europium-Based Quantitative Lateral Flow Immunoassay for the Chronic Kidney Disease Marker Cystatin-C. J Fluoresc 2022. [PMID: 35025016 DOI: 10.1007/s10895-021-02886-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gumus E, Bingol H, Zor E. Lateral flow assays for detection of disease biomarkers. J Pharm Biomed Anal 2023;225:115206. [PMID: 36586382 DOI: 10.1016/j.jpba.2022.115206] [Reference Citation Analysis]
2 Chhillar M, kukkar D, Kukkar P, Kim K. Nanoparticle-antibody conjugate-based immunoassays for detection of CKD-associated biomarkers. TrAC Trends in Analytical Chemistry 2022. [DOI: 10.1016/j.trac.2022.116857] [Reference Citation Analysis]
3 Li H, Wu P, Zeng N, Liu Y, Alsaadi FE. A survey on parameter identification, state estimation and data analytics for lateral flow immunoassay: from systems science perspective. International Journal of Systems Science. [DOI: 10.1080/00207721.2022.2083262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]